Nicolas Lamblin

Nicolas Lamblin

Auto-generated profile, based on publicly available information

Nicolas Lamblin

Cardiology Department, Heart and Lung Institute, University Hospital of Lille, CHU Lille , Bd du Pr Jules Lecle rcq, 59000 Lille

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2009 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
AHA-L Hachulla
A-L Hachulla
DLDavid Launay
David Launay
VGV Gaxotte
V Gaxotte
PGP de Groote
P de Groote
NLN Lamblin
N Lamblin
EHE Hachulla
E Hachulla
Objectives: To assess the prevalence and patterns of cardiac abnormalities as detected by cardiac magnetic resonance imaging (MRI) in systemic sclerosis (SSc). Methods: Fifty-two consecutive patients with SSc underwent cardiac MRI to determine morphological, functional, perfusion at rest and delayed enhancement abnormalities. Results: At least one abnormality on cardiac MRI was observed in 39/52 patients (75%). Increased myocardial signal intensity in T2 was observed in 6 patients (12%), thinning of left ventricle (LV) myocardium in 15 patients (29%) and pericardial effusion in 10 patients (19%). LV and right ventricle (RV) ejection fractions were altered in 12 patients (23%) and 11 patients (21%), respectively. LV diastolic dysfunction was found in 15/43 patients (35%). LV kinetic abnormalities were found in 16/52 patients (31%) and myocardial delayed contrast enhancement was detected in 11/52 patients (21%). No perfusion defects at rest were found. Patients with limited SSc had similar MRI abnormalities to patients with diffuse SSc. Seven of 40 patients (17%) without pulmonary arterial hypertension had RV dilatation. Conclusions: This study shows that MRI is a reliable and sensitive technique for diagnosing heart involvement in SSc and for analysing its mechanisms, including its inflammatory, microvascular and fibrotic components. Compared with echocardiography, MRI appears to provide additional information by visualising myocardial fibrosis and inflammation. RV dilatation appeared to be non-specific for pulmonary arterial hypertension but could also reflect myocardial involvement related to SSc. Further studies are needed to determine whether cardiac MRI abnormalities have an impact on the prognosis and treatment strategy.

1 July 2002 in JACC
Verified
Journal Article
Closed access
NLNicolas Lamblin
Nicolas Lamblin
CBChristophe Bauters
Christophe Bauters
XHXavier Hermant
Xavier Hermant
JLJean-Marc Lablanche
Jean-Marc Lablanche
NHNicole Helbecque
Nicole Helbecque
PAPhilippe Amouyel
Philippe Amouyel

8 January 2003 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
CBChristophe Bauters
Christophe Bauters
NLNicolas Lamblin
Nicolas Lamblin
EFEugène P Mc Fadden
Eugène P Mc Fadden
EBEric Van Belle
Eric Van Belle
AMAlain Millaire
Alain Millaire
PGPascal de Groote
Pascal de Groote
Our aim is to summarize and discuss the recent literature linking diabetes mellitus with heart failure, and to address the issue of the optimal treatment for diabetic patients with heart failure.

30 May 2018 in European Radiology
Verified
Journal Article
Closed access
PDF file
MMMatthieu Masy
Matthieu Masy
JGJessica Giordano
Jessica Giordano
GPGrégory Petyt
Grégory Petyt
CHClaude Hossein-Foucher
Claude Hossein-Foucher
ADAlain Duhamel
Alain Duhamel
MRMartine Remy-Jardin
Martine Remy-Jardin

1 January 2008 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
PGP de Groote
P de Groote
VGV Gressin
V Gressin
EHE Hachulla
E Hachulla
PCP Carpentier
P Carpentier
LGL Guillevin
L Guillevin
MHM Humbert
M Humbert
Objectives: There is increasing concern about heart and pulmonary vascular involvement in systemic sclerosis (SSc). One of the most severe complications of SSc is pulmonary arterial hypertension (PAH). There has been an increased awareness of left ventricular (LV) diastolic abnormalities in SSc patients. However, previous studies have generally been conducted in small populations. The aims of this study were to prospectively screen for PAH and to describe echocardiographic parameters in a large group of SSc patients. Methods: This prospective study was conducted in 21 centres for SSc in France. Patients without severe pulmonary function abnormalities, severe cardiac disease and known PAH underwent Doppler echocardiography performed by a reference cardiologist. Results: Of the 570 patients evaluated, PAH was suspected in 33 patients and was confirmed in 18 by right heart catheterisation. LV systolic dysfunction was rare (1.4%). LV hypertrophy was found in 22.6%, with LV diastolic dysfunction in 17.7%. These LV abnormalities were influenced by age, gender and blood pressure. We identified a small group of 21 patients with a restrictive mitral flow pattern in the absence of any other cardiopulmonary diseases, suggesting a specific cardiac involvement in SSc. Conclusions: Left and right heart diseases, including PAH, LV hypertrophy and diastolic dysfunction, are common in SSc. However, a small subset of patients without any cardiac or pulmonary diseases have a restrictive mitral flow pattern that could be due to primary cardiac involvement of SSc. The prognostic implications of the LV abnormalities will be evaluated in the 3-year follow-up of this cohort.

1 June 2018 in JACC: Heart Failure
Verified
Journal Article
Closed access
MCMarco Canepa
Marco Canepa
CFCandida Fonseca
Candida Fonseca
OCOvidiu Chioncel
Ovidiu Chioncel
CLCécile Laroche
Cécile Laroche
MCMaria G. Crespo-Leiro
Maria G. Crespo-Leiro
HGH. Gunes
H. Gunes